Collaborative Management of Medication-Induced Dyslipidemia: The Role of Pharmacists and Laboratory Specialists in Optimizing Patient Outcomes

Authors: Alaa M. Alsayyari, Alaa S. Aleiid, Jehan H. Ben Hyzaam, Ranya F. Arab, Amal T. Alenazi, Hala H. Almutairi, Rayyan D. Alotaibi, Nujud K. Hajij, Waleed A Alrogy

DOI: https://doi.org/10.5281/zenodo.13879437

Short DOI: https://doi.org/g6k94v

Country: Saudi Arabia

Full-text Research PDF File:   View   |   Download

Abstract: Background: Medication-induced dyslipidemia is a significant risk factor for cardiovascular diseases, particularly in patients taking chronic medications such as corticosteroids and antipsychotics. This study aimed to assess the impact of pharmacist and laboratory specialist collaboration in managing medication-induced dyslipidemia in a tertiary hospital setting.

Methods: A retrospective cohort study was conducted with 200 patients on chronic medications known to induce dyslipidemia. The intervention group (n = 100) received collaborative care from pharmacists and laboratory specialists, while the control group (n = 100) received standard care. Primary outcomes included changes in lipid profiles over six months. Secondary outcomes included cardiovascular events, medication adherence, and patient satisfaction.

Results: The intervention group showed significant improvements in lipid profiles, with reductions in total cholesterol (211 mg/dL to 185 mg/dL, p < 0.001) and LDL (141 mg/dL to 110 mg/dL, p < 0.001), compared to the control group. Cardiovascular events were lower in the intervention group (8% vs. 14%, p = 0.041), and medication adherence was higher (86% vs. 73%, p = 0.022). Patient satisfaction with pharmacist-led interventions was also significantly higher (92% vs. 68%, p < 0.001).

Conclusion: Collaboration between pharmacists and laboratory specialists significantly improves lipid management and reduces cardiovascular risk in patients with medication-induced dyslipidemia. This interdisciplinary approach enhances patient outcomes and should be integrated into routine care for patients on chronic medications.

Keywords: Medication-induced dyslipidemia, pharmacists, laboratory specialists, lipid profiles, cardiovascular risk, interdisciplinary care

Paper Id: 231275

Published On: 2020-06-02

Published In: Volume 8, Issue 3, May-June 2020

Cite This: Collaborative Management of Medication-Induced Dyslipidemia: The Role of Pharmacists and Laboratory Specialists in Optimizing Patient Outcomes - Alaa M. Alsayyari, Alaa S. Aleiid, Jehan H. Ben Hyzaam, Ranya F. Arab, Amal T. Alenazi, Hala H. Almutairi, Rayyan D. Alotaibi, Nujud K. Hajij, Waleed A Alrogy - IJIRMPS Volume 8, Issue 3, May-June 2020. DOI 10.5281/zenodo.13879437

Share this